These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37505011)

  • 1. Interactions of the Kv1.1 Channel with Peptide Pore Blockers: A Fluorescent Analysis on Mammalian Cells.
    Orlov NA; Kryukova EV; Efremenko AV; Yakimov SA; Toporova VA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Membranes (Basel); 2023 Jul; 13(7):. PubMed ID: 37505011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining mKate2-Kv1.3 Channel and Atto488-Hongotoxin for the Studies of Peptide Pore Blockers on Living Eukaryotic Cells.
    Orlov NA; Ignatova AA; Kryukova EV; Yakimov SA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Toxins (Basel); 2022 Dec; 14(12):. PubMed ID: 36548755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atto488-Agitoxin 2-A Fluorescent Ligand with Increased Selectivity for Kv1.3 Channel Binding Site.
    Denisova KR; Orlov NA; Yakimov SA; Kirpichnikov MP; Feofanov AV; Nekrasova OV
    Bioengineering (Basel); 2022 Jul; 9(7):. PubMed ID: 35877346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.
    Nekrasova OV; Primak AL; Ignatova AA; Novoseletsky VN; Geras'kina OV; Kudryashova KS; Yakimov SA; Kirpichnikov MP; Arseniev AS; Feofanov AV
    Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33339256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel.
    Nekrasova OV; Volyntseva AD; Kudryashova KS; Novoseletsky VN; Lyapina EA; Illarionova AV; Yakimov SA; Korolkova YV; Shaitan KV; Kirpichnikov MP; Feofanov AV
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):260-276. PubMed ID: 27640211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AgTx2-GFP, Fluorescent Blocker Targeting Pharmacologically Important K
    Primak AL; Orlov NA; Peigneur S; Tytgat J; Ignatova AA; Denisova KR; Yakimov SA; Kirpichnikov MP; Nekrasova OV; Feofanov AV
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering-specific pharmacological binding sites for peptidyl inhibitors of potassium channels into KcsA.
    Legros C; Schulze C; Garcia ML; Bougis PE; Martin-Eauclaire MF; Pongs O
    Biochemistry; 2002 Dec; 41(51):15369-75. PubMed ID: 12484776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GFP-Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers.
    Denisova KR; Orlov NA; Yakimov SA; Kryukova EA; Dolgikh DA; Kirpichnikov MP; Feofanov AV; Nekrasova OV
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and application of cy-dye- and alexa-dye-labeled hongotoxin(1) analogues. The first high affinity fluorescence probes for voltage-gated K+ channels.
    Pragl B; Koschak A; Trieb M; Obermair G; Kaufmann WA; Gerster U; Blanc E; Hahn C; Prinz H; Schütz G; Darbon H; Gruber HJ; Knaus HG
    Bioconjug Chem; 2002; 13(3):416-25. PubMed ID: 12009929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding modes of two scorpion toxins to the voltage-gated potassium channel kv1.3 revealed from molecular dynamics.
    Chen R; Chung SH
    Toxins (Basel); 2014 Jul; 6(7):2149-61. PubMed ID: 25054783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subunit composition of brain voltage-gated potassium channels determined by hongotoxin-1, a novel peptide derived from Centruroides limbatus venom.
    Koschak A; Bugianesi RM; Mitterdorfer J; Kaczorowski GJ; Garcia ML; Knaus HG
    J Biol Chem; 1998 Jan; 273(5):2639-44. PubMed ID: 9446567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K
    Kuzmenkov AI; Nekrasova OV; Peigneur S; Tabakmakher VM; Gigolaev AM; Fradkov AF; Kudryashova KS; Chugunov AO; Efremov RG; Tytgat J; Feofanov AV; Vassilevski AA
    Neuropharmacology; 2018 Dec; 143():228-238. PubMed ID: 30248306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeras of KcsA and Kv1 as a bioengineering tool to study voltage-gated potassium channels and their ligands.
    Kudryashova KS; Nekrasova OV; Kirpichnikov MP; Feofanov AV
    Biochem Pharmacol; 2021 Aug; 190():114646. PubMed ID: 34090876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.
    Suarez-Kurtz G; Vianna-Jorge R; Pereira BF; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1517-22. PubMed ID: 10336547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.
    Kudryashova KS; Nekrasova OV; Kuzmenkov AI; Vassilevski AA; Ignatova AA; Korolkova YV; Grishin EV; Kirpichnikov MP; Feofanov AV
    Anal Bioanal Chem; 2013 Mar; 405(7):2379-89. PubMed ID: 23307127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.
    Kuzmenkov AI; Vassilevski AA; Kudryashova KS; Nekrasova OV; Peigneur S; Tytgat J; Feofanov AV; Kirpichnikov MP; Grishin EV
    J Biol Chem; 2015 May; 290(19):12195-209. PubMed ID: 25792741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial pore blocker acts specifically on voltage-gated potassium channel isoform K
    Gigolaev AM; Lushpa VA; Pinheiro-Junior EL; Tabakmakher VM; Peigneur S; Ignatova AA; Feofanov AV; Efremov RG; Mineev KS; Tytgat J; Vassilevski AA
    J Biol Chem; 2022 Nov; 298(11):102467. PubMed ID: 36087839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating a high affinity scorpion toxin receptor in KcsA-Kv1.3 chimeric potassium channels.
    Legros C; Pollmann V; Knaus HG; Farrell AM; Darbon H; Bougis PE; Martin-Eauclaire MF; Pongs O
    J Biol Chem; 2000 Jun; 275(22):16918-24. PubMed ID: 10828071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the potency and selectivity of Urotoxin, a potent Kv1 blocker from scorpion venom.
    Luna-Ramirez K; Csoti A; McArthur JR; Chin YKY; Anangi R; Najera RDC; Possani LD; King GF; Panyi G; Yu H; Adams DJ; Finol-Urdaneta RK
    Biochem Pharmacol; 2020 Apr; 174():113782. PubMed ID: 31881193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.